Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.
about
Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression.Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.Role of argatroban during neurointerventional procedures in patients with heparin induced thrombocytopenia.A random forest based risk model for reliable and accurate prediction of receipt of transfusion in patients undergoing percutaneous coronary intervention.Impact of renal dysfunction on long-term outcomes of elderly patients with acute coronary syndrome: a longitudinal, prospective observational study.Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry.Clopidogrel "resistance": where are we now?Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary interventionStandardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumDual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE studyBleeding risk stratification in an era of aggressive management of acute coronary syndromesPeriprocedural hemoglobin changes and myocardial injury in patients undergoing percutaneous coronary interventionChanges in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initValidity of a PCI Bleeding Risk Score in patient subsets stratified for body mass indexImplications of bleeding in acute coronary syndrome and percutaneous coronary intervention.Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database.Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks.Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes.Effect of enoxaparin on clinical events after percutaneous coronary intervention.Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplastyThe association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarctionBivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.A comparison of the transradial and transfemoral approaches for the angiography and intervention in patients with a history of coronary artery bypass surgery: in-hospital and 1-year follow-up results.Incidence, Time Trends, and Predictors of Intracranial Hemorrhage During Long-Term Follow-up After Acute Myocardial InfarctionClopidogrel variability: role of plasma protein binding alterationsBLEED-Myocardial Infarction Score: Predicting mid-term post-discharge bleeding events.Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent RegistryDuration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.Prognostic significance of bleeding location and severity among patients with acute coronary syndromes.Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndromeThe prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.Clopidogrel before elective percutaneous coronary intervention.Prognostic score for acute coronary syndrome in a private terciary hospital.Decision-making: stenting in acute myocardial infarction.Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device.How serious a problem is bleeding in patients with acute coronary syndromes?Managing adverse effects and drug-drug interactions of antiplatelet agents.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiAnaemia and prognosis in acute coronary syndromes: a systematic review and meta-analysis.Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.
P2860
Q30239889-77A3A0B0-DB8E-41E6-899C-D7450666A9CCQ33391484-E582D91C-CAD5-49C0-9CAF-7AFE1C365987Q33410515-EE5C167C-9369-46A9-9A42-B78A6140CB96Q33590075-D862A63E-F6DD-4815-A1EC-98306D3E014BQ33716941-6BA10276-845E-4EF3-B856-C259C5A493C7Q33865395-B27DBA30-F829-42A7-BDFB-FC45457678BDQ34212563-8FFB5131-AFEA-417B-BA79-4FD41BC9B45DQ34254766-585A4404-3BE7-45F3-BFE7-958161C843F6Q34492675-3C7D5E30-A8C5-45F2-A571-5030CE78CDBDQ34531925-4CE697E6-F249-48AF-B15F-CF9478372436Q34574018-BE22167F-3728-416B-BA87-4318364D68E4Q34621093-5EC3A5FD-63E6-42FF-B245-EF0902E087E7Q34683098-F9BE7F83-961A-4C9A-AB11-AC5A2A50B687Q35137974-0ACE736B-CD88-4F44-BEA7-FD3130FC135FQ35193938-A91F80B6-71E0-4EA9-95CC-74B269F5119BQ35600968-686FF706-C9DE-41CD-A61F-A37871F83EC1Q35714397-ECB8C937-ADD0-48DA-8497-03C13FC50983Q35928767-CE79514C-530E-4FE2-9493-ADC79802C5C4Q36046275-68734ACC-BBB1-4F95-904A-25537B99362DQ36095614-9CCAAC50-1813-4297-A35C-E37D70B235ACQ36162429-D92FC7C2-FB0A-4EF9-86FC-C15DC9CD618CQ36251279-F2CFCFDB-FFC2-4F0B-80BC-23BBBBB40015Q36804764-411C7662-1648-4F94-9F9D-D06230166622Q36836368-D2AB1E18-6277-4219-BC18-71BEB85E114DQ36948114-DA0EBDD3-200A-43BE-A440-EE6228EF4AC7Q36952116-82082552-C99A-4DCC-B69D-02EF7726040DQ37040299-EF43BD84-03B8-446F-A370-DBBEF4751B5DQ37291851-9B8729E3-7686-48AB-86CB-4CCC966E5484Q37448908-36DDA4A8-7049-42E7-9F2E-550902C19BA4Q37561885-11D73CA2-9280-432C-98AE-D5ABCE6521D4Q37599599-0EBDB122-BE2D-4F69-A056-CD595CB44E9FQ37605466-32BE9E80-F091-42F3-90CF-E650F4D87790Q37703777-DEAC23BF-B4F8-4A64-8141-910A96F90F75Q37749818-963E5743-530F-4A17-8882-CE9B116A77D1Q37756348-D4208460-2606-4E4C-A155-D39628E2A6AAQ37888541-1FE6A960-38B6-47A4-B40D-52C56ACDC014Q37930967-5F43B505-572B-4CF2-85F6-2B3FED3AA32EQ37953885-C7768F4D-7CD7-4931-B5B2-5847E6BCF324Q37994862-B611A41E-531D-471C-AAD9-E4FA6774CBD3Q38021699-CF928696-814D-4DA3-80F9-C93D618D6232
P2860
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@en
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@nl
type
label
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@en
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@nl
prefLabel
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@en
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@nl
P2093
P50
P1476
Predictors and impact of major ...... tion from the REPLACE-2 Trial.
@en
P2093
Frederick Feit
John A Bittl
Michele D Voeltz
Steven V Manoukian
P304
P356
10.1016/J.AMJCARD.2007.06.026
P407
P577
2007-08-16T00:00:00Z